Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott M Lippman

Showing results (51-60 of 340) with videos related to

Pageof 34
Sort By:
Cytokine & Growth Factor Reviews|January 28, 2025
Interleukin-17: A pleiotropic cytokine implicated in inflammatory, infectious, and malignant disordersAnushka Saran, Daisuke Nishizaki, Scott M Lippman, et al.
Nature Reviews. Drug Discovery|February 28, 2009
Molecular targets for cancer chemopreventionWilliam N William, John V Heymach, Edward S Kim, et al.
Cancer|February 7, 2009
Cyclooxygenase-2 gene polymorphisms reduce the risk of oral premalignant lesionsXia Pu, Scott M Lippman, Hushan Yang, et al.
Cancer Research|December 3, 2004
The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces apoptosis via induction of 15-lipoxygenase-1 in colorectal cancer cellsLinda C Hsi, Xiaopei Xi, Reuben Lotan, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|April 25, 2017
Longitudinal thumbnail fissures due to erlotinib therapy for lung cancerConstantin A Dasanu, Juliana Alvarez-Argote, Scott M Lippman, et al.
Cancer Research|April 3, 2003
Identification of benzo(a)pyrene diol epoxide-binding DNA fragments using DNA immunoprecipitation techniqueZhengdong Liang, Scott M Lippman, Atsushi Kawabe, et al.
Molecular Cancer Therapeutics|May 16, 2003
Dominant negative signal transducer and activator of transcription 2 (STAT2) protein: stable expression blocks interferon alpha action in skin squamous cell carcinoma cellsJohn L Clifford, Xiulan Yang, Eugene Walch, et al.
Frontiers in Oncology|March 30, 2023
Cancer, more than a "COVID-19 co-morbidity"Chinmay T Jani, Robert T Schooley, Rana R Mckay, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 10, 2005
Phase III prostate cancer prevention trials: are the costs justified?Ian M Thompson, Catherine M Tangen, Eric A Klein, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 10, 2004
Peroxisome proliferator-activated receptor-gamma suppresses cyclooxygenase-2 expression in human prostate cellsAnita L Sabichi, Vemparala Subbarayan, Norma Llansa, et al.
Pageof 34

Showing results (51-60 of 340) with videos related to

Sort By:
Pageof 34
Cytokine & Growth Factor Reviews|January 28, 2025
Interleukin-17: A pleiotropic cytokine implicated in inflammatory, infectious, and malignant disordersAnushka Saran, Daisuke Nishizaki, Scott M Lippman, et al.
Nature Reviews. Drug Discovery|February 28, 2009
Molecular targets for cancer chemopreventionWilliam N William, John V Heymach, Edward S Kim, et al.
Cancer|February 7, 2009
Cyclooxygenase-2 gene polymorphisms reduce the risk of oral premalignant lesionsXia Pu, Scott M Lippman, Hushan Yang, et al.
Cancer Research|December 3, 2004
The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces apoptosis via induction of 15-lipoxygenase-1 in colorectal cancer cellsLinda C Hsi, Xiaopei Xi, Reuben Lotan, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|April 25, 2017
Longitudinal thumbnail fissures due to erlotinib therapy for lung cancerConstantin A Dasanu, Juliana Alvarez-Argote, Scott M Lippman, et al.
Cancer Research|April 3, 2003
Identification of benzo(a)pyrene diol epoxide-binding DNA fragments using DNA immunoprecipitation techniqueZhengdong Liang, Scott M Lippman, Atsushi Kawabe, et al.
Molecular Cancer Therapeutics|May 16, 2003
Dominant negative signal transducer and activator of transcription 2 (STAT2) protein: stable expression blocks interferon alpha action in skin squamous cell carcinoma cellsJohn L Clifford, Xiulan Yang, Eugene Walch, et al.
Frontiers in Oncology|March 30, 2023
Cancer, more than a "COVID-19 co-morbidity"Chinmay T Jani, Robert T Schooley, Rana R Mckay, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 10, 2005
Phase III prostate cancer prevention trials: are the costs justified?Ian M Thompson, Catherine M Tangen, Eric A Klein, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 10, 2004
Peroxisome proliferator-activated receptor-gamma suppresses cyclooxygenase-2 expression in human prostate cellsAnita L Sabichi, Vemparala Subbarayan, Norma Llansa, et al.
Pageof 34